Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

410 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Ovarian cancer creates a suppressive microenvironment to escape immune elimination.
Yigit R, Massuger LF, Figdor CG, Torensma R. Yigit R, et al. Among authors: massuger lf. Gynecol Oncol. 2010 May;117(2):366-72. doi: 10.1016/j.ygyno.2010.01.019. Epub 2010 Feb 9. Gynecol Oncol. 2010. PMID: 20144842 Review.
Specific and nonspecific immunoassays to detect HAMA after administration of indium-111-labeled OV-TL 3 F(ab')2 monoclonal antibody to patients with ovarian cancer.
Massuger LF, Thomas CM, Segers MF, Corstens FH, Verheijen RH, Kenemans P, Poels LG. Massuger LF, et al. J Nucl Med. 1992 Nov;33(11):1958-63. J Nucl Med. 1992. PMID: 1432156
Tumour detection and localization using 99Tcm-labelled OV-TL 3 Fab' in patients suspected of ovarian cancer.
Tibben JG, Massuger LF, Claessens RA, Schijf CP, Pak KY, Strijk SP, Kenemans P, Corstens FH. Tibben JG, et al. Among authors: massuger lf. Nucl Med Commun. 1992 Dec;13(12):885-93. doi: 10.1097/00006231-199212000-00006. Nucl Med Commun. 1992. PMID: 1465272
Dosimetric evaluation of immunoscintigraphy using indium-111-labeled monoclonal antibody fragments in patients with ovarian cancer.
Buijs WC, Massuger LF, Claessens RA, Kenemans P, Corstens FH. Buijs WC, et al. Among authors: massuger lf. J Nucl Med. 1992 Jun;33(6):1113-20. J Nucl Med. 1992. PMID: 1597725
Tissue distribution of 99mTc, 111In and 123I-OV-TL 3 Fab' in ovarian carcinoma bearing nude mice.
Massuger LF, Claessens RA, Pak KY, Boerman OC, Daddona PE, Koenders EB, Kenemans P, Corstens FH. Massuger LF, et al. Int J Rad Appl Instrum B. 1991;18(1):77-83. doi: 10.1016/0883-2897(91)90051-l. Int J Rad Appl Instrum B. 1991. PMID: 1707043 No abstract available.
Detection and localization of ovarian cancer with radiolabeled monoclonal antibodies.
Massuger LF, Kenemans P, Claessens RA, Verheijen RH, Corstens FH. Massuger LF, et al. Eur J Obstet Gynecol Reprod Biol. 1991 Aug 20;41(1):47-63. doi: 10.1016/0028-2243(91)90319-g. Eur J Obstet Gynecol Reprod Biol. 1991. PMID: 1748227 Review. No abstract available.
Biodistribution of iodine-125 and indium-111 labeled OV-TL 3 intact antibodies and F(ab')2 fragments in tumor-bearing athymic mice.
Massuger LF, Boerman OC, Corstens FH, Verheijen RH, Claessens RA, Poels LG, van den Broek WJ, Kenemans P. Massuger LF, et al. Anticancer Res. 1991 Nov-Dec;11(6):2051-7. Anticancer Res. 1991. PMID: 1776839
Kinetics and biodistribution in relation to tumour detection with 111In-labelled OV-TL 3 F(ab')2 in patients with ovarian cancer.
Massuger LF, Claessens RA, Kenemans P, Verheijen RH, Boerman OC, Meeuwis AP, Schijf CP, Buijs WC, Hanselaar TG, Corstens FH. Massuger LF, et al. Nucl Med Commun. 1991 Jul;12(7):593-609. doi: 10.1097/00006231-199107000-00004. Nucl Med Commun. 1991. PMID: 1923151
Carcinoma-associated mucin serum markers CA M26 and CA M29: efficacy in detecting and monitoring patients with cancer of the breast, colon, ovary, endometrium and cervix.
Yedema KA, Kenemans P, Wobbes T, van Kamp GJ, de Bruijn HW, Thomas CM, Massuger LF, Schijf CP, Bon GG, Vermorken JB, et al. Yedema KA, et al. Among authors: massuger lf. Int J Cancer. 1991 Jan 21;47(2):170-9. doi: 10.1002/ijc.2910470203. Int J Cancer. 1991. PMID: 1988362
Immunoscintigraphy of ovarian cancer with indium-111-labeled OV-TL 3 F(ab')2 monoclonal antibody.
Massuger LF, Kenemans P, Claessens RA, Verheijen RH, Schijf CP, Strijk SP, Poels LG, van Hoesel RG, Corstens FH. Massuger LF, et al. J Nucl Med. 1990 Nov;31(11):1802-10. J Nucl Med. 1990. PMID: 2230993 Clinical Trial.
410 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page